Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease

This billing and coding guidance covers the MolDX Prostate Cancer Genomic Classifier assay for men with localized prostate cancer (ICD-10-CM C61). Claims must report the applicable CPT code with 1 unit of service, include the appropriate DEX Z-Code identifier in the specified Part A/Part B claim fields, and list ICD-10-CM code C61; clinical coverage criteria are governed by LCD L38292.

"Prostate cancer in men with localized disease (use ICD-10-CM code C61)."

Sign up to see full coverage criteria, indications, and limitations.